Cannabis Science Information

12/31/2025

For 15 years, James has lived through levels of pain most people can’t imagine—nerve damage, spinal issues, diverticulitis, arthritis, a near-fatal head-on collision, and a lifetime of accumulated injuries. Traditional medications brought new problems, old problems didn’t go away, and hope seemed further out of reach. Then came one moment that changed everything

For 15 years, James has lived through levels of pain most people can’t imagine—nerve damage, spinal issues, diverticulitis, arthritis, a near-fatal head-on c...

12/31/2025

What if everything you’ve been told about treating Alzheimer’s symptoms is only half the story? In this emotional, no-BS conversation, cannabis advocate James Tripp shares how he used cannabinoid therapy to calm his mother’s late-stage Alzheimer’s symptoms, transform brutal days at home, and push a long-term care home to rewrite its policies.

What if everything you’ve been told about treating Alzheimer’s symptoms is only half the story? In this emotional, no-BS conversation, cannabis advocate Jam...

12/31/2025

12/03/2025

https://www.youtube.com/live/_8UqvF06oew

The PACE Radio Show - Guests: Kim Saltarski & James TrippThis week we welcome documentary creator Kim Saltarski of Ain’t It Amazing’s The Healing Conversatio...

05/14/2025

Highlights

•The Endocannabinoid System (ECS) is a physiological system essential for maintaining CNS homeostasis and regulating neurological functions.

•ECS and cannabinoid receptors (CBRs) play a crucial role in several neurological disorders.

•The cannabinoid type 2 receptor (CB2R) is a promising therapeutic target due to its neuroprotective effects without CB1R-related psychotropic effects.

•Although the effects of CB2R agonists are numerous, clinical studies conducted to date are still limited.

05/14/2025

-----------------
Results: The meta-analysis revealed a significant consensus supporting the use of medical cannabis in the categories of health metrics, cancer treatments, and cancer dynamics. The aggregated correlation strength of cannabis across all cancer topics indicates that support for medical cannabis is 31.38× stronger than opposition to it. The analysis highlighted the anti-inflammatory potential of cannabis, its use in managing cancer-related symptoms such as pain, nausea, and appetite loss, and explored the consensus on its use as an anticarcinogenic agent.
-----------------

Background: Growing bodies of evidence suggest that cannabis may play a significant role in both oncological palliative care and as a direct anticarcinogenic agent, but classification as a Schedule I substance has complicated research into its therapeutic potential, leaving the state of research sca...

10/21/2024

https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2024.1309167/full

Discoid lupus erythematosus (DLE) is a common autoimmune skin disease in dogs. Conventional treatments, such as corticosteroids, can be effective but often h...